Skip to main content

Advertisement

Fig. 7 | Cell & Bioscience

Fig. 7

From: Genome editing of the HIV co-receptors CCR5 and CXCR4 by CRISPR-Cas9 protects CD4+ T cells from HIV-1 infection

Fig. 7

Apoptosis analysis after lenti-X4R5-Cas9 modification in primary CD4+ T cells. a Annexin V and 7-AAD were utilized to stain modified CD4+T at 1,3 and 5 days post nucleofection with flow cytometry. Necrotic cells (Annexin V-/7AAD +), necrotic or late apoptotic cells (Annexin V +/7AAD +); early apoptotic cells (Annexin V +/7AAD-); viable cells (Annexin V-/7AAD-). b Early apoptosis ratio at day 1,3,5 post gene disruption. c relative early apoptosis ratio (Q3/total none viable cells). The total none viable cells = Q2 + Q3. The data shown were the mean ± SD of three independent experiments. *P < 0.05

Back to article page